Incidence of lymph node and XXXX in @entity1822 .

@entity43 @entity1 @entity1822 @entity3
OBJECTIVE: The purpose of this study was to determine the incidence of lymph node and @entity43 in newly diagnosed @entity1822 ( @entity1822 ), and to describe possible predictive factors. METHODS: We used our prospectively acquired databases to identify 275 consecutive @entity1 with uterine @entity1822 treated from 7/82 to 12/01. @entity1 were included if there was clear documentation of lymph nodes and/or ovarian tissue in the pathologic reports. Clinical data were extracted from electronic medical records. Statistical analysis using the Fisher exact test was used to determine prognostic factors. RESULTS: There were 108 @entity1 (39.2%) identified in whom an oophorectomy and 37 @entity1 (13.5%) in whom lymph node sampling was performed as part of the initial surgical management of uterine @entity1822 . Bilateral oophorectomy was performed in 102 (94.4%) of the 108 @entity1 . The median numbers of pelvic, para-aortic, and total lymph nodes acquired were 5 (range, 1-27), 3 (range, 1-9), and 6 (range, 1-34), respectively. Ovarian @entity3 were found in 4 (3.9%) out of 108 @entity1 . Two (2.8%) of the 71 @entity1 with disease confined to the uterus and/or cervix (stage I/II) and 2 (5.4%) of the 37 @entity1 with gross extrauterine disease had @entity43 (P = 0.43). Positive lymph nodes were seen in 3 (8.1%) of 37 @entity1 . No @entity1 with stage I/II disease had positive lymph nodes (P = 0.015). None of the factors analyzed predicted for @entity3 to the ovary. Only the presence or absence of gross extrauterine disease correlated with lymph node @entity3 . In addition, all three of these cases had clinically suspicious (enlarged) lymph nodes. CONCLUSIONS: The incidence of ovarian and lymph node @entity3 in uterine @entity1822 is very low and is most commonly associated with extrauterine disease. Lymph node dissection for uterine @entity1822 should be reserved for @entity1 with clinically suspicious nodes.
